Jyong Biotech MENS
NASDAQ MENS
$1.77 +0.03 (+1.72%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Total Debt (2024 - 2025)

Updated

Jyong Biotech's Total Debt was $9.84 million in the quarter ended Dec 31, 2025, up 5.6% from $9.31 million a year earlier.

Analysis

Jyong Biotech (MENS) Total Debt (2024 - 2025) Analysis & Trends

  • In earlier years, Total Debt was $9.31 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 44.65 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 70.82 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 63.19 Bn
10 Jyong Biotech 129.23 Mn 129.23 Mn - 9.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 9.84 Mn
Jun 30, 2025 24.73 Mn
Dec 31, 2024 9.31 Mn
API Access

Jyong Biotech Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=MENS&period=max&api_key=YOUR_API_KEY